Atlanta, GEORGIA2 Active Studies

Dravet Syndrome Clinical Trials in Atlanta, GEORGIA

Find 2 actively recruiting dravet syndrome clinical trials in Atlanta, GEORGIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
310
Enrolling

Recruiting Dravet Syndrome Studies in Atlanta

About Dravet Syndrome Clinical Trials in Atlanta

Dravet syndrome is a rare, severe form of epilepsy that begins in the first year of life with prolonged seizures often triggered by fever. It is usually caused by mutations in the SCN1A gene. Treatment includes specific antiseizure medications, avoiding certain drugs that can worsen seizures, and investigational gene therapies.

There are currently 2 dravet syndrome clinical trials recruiting participants in Atlanta, GEORGIA. These studies are seeking a combined 310 participants. Research is being sponsored by Longboard Pharmaceuticals, Epygenix. Clinical trial participation is free and participants receive study-related medical care at no cost.

Dravet Syndrome Clinical Trials in Atlanta — FAQ

Are there dravet syndrome clinical trials in Atlanta?

Yes, there are 2 dravet syndrome clinical trials currently recruiting in Atlanta, GEORGIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What dravet syndrome treatments are being tested?

The 2 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for dravet syndrome.

Data updated March 2, 2026 from ClinicalTrials.gov